Add-on Acquisition • Life Science

LucyRx Acquires CerpassRx

On July 31, 2025, LucyRx acquired life science company CerpassRx

Acquisition Context

This is LucyRx’s 1st transaction in the Life Science sector.
This is LucyRx’s 1st transaction in the United States.
This is LucyRx’s 1st transaction in Texas.

Explore All 3111 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	July 31, 2025
Target	CerpassRx
Sector	Life Science
Buyer(s)	LucyRx
Deal Type	Add-on Acquisition

Target Company

CerpassRx

The Colony, Texas, United States

CerpassRx is a full-service, pharmacy benefit manager that offers prescription optimization, flexible formulary designs, personalized member support, and efficient mail and specialty pharmacy programs. CerpassRx is based in The Colony, Texas.

Explore More Deals

Browse All 215,158 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

LucyRx

Bethesda, Maryland, United States

Category	Company
Sector	Internet Software and Services

DESCRIPTION

LucyRx is a pharmacy benefit manager (PBM) redefining prescription care that delivers better outcomes through its integrated specialty network, formulary marketplace, and next-day home delivery solutions. Powered by its proprietary AI platform, LucyIQ, the company provides real-time insights that support evidence-based clinical decisions, clear pricing, and exceptional service from U.S.-based pharmacy technicians. LucyRx is based in Bethesda, Maryland.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Texas	1 of 1
Country: United States	1 of 1
Year: 2025	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Texas M&A - United States M&A - 2025 M&A